Question 1

Does Citadel Advisors own ATON stock?

Accepted Answer

Yes. As of its Q2 2026 13F, Citadel Advisors holds 55,182 shares of ATON (Portage Biotech), worth $14,016.

Question 2

How many shares of ATON does Citadel Advisors own?

Accepted Answer

As of its Q2 2026 13F, Citadel Advisors holds 55,182 shares of ATON (Portage Biotech).

Question 3

What is Citadel Advisors' ATON position worth?

Accepted Answer

As of its Q2 2026 13F, Citadel Advisors' ATON position is worth $14,016.

Question 4

Is Citadel Advisors buying or selling ATON?

Accepted Answer

In Q2 2026, Citadel Advisors opened a new ATON position of 55,182 shares.

Question 5

When did Citadel Advisors first buy ATON?

Accepted Answer

Citadel Advisors first reported ATON in its Q4 2024 13F and has listed it in 2 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	New	55,182	-	$14,016	0.0%	$12.70	27
2025-Q1	Exited	0	-100.0%	$0	0.0%	$462.50	0
2024-Q4	New	15,431	-	$79,778	0.0%	$258.50	33

ATON3 quarters

ATON
3 quarters